TTK Healthcare Ltd-$
TTK Healthcare Ltd-$ (TTKHLTCARE) last reported results for the quarter ended Jun 2026, with sales of ₹258 crore and net profit of ₹21 crore. The stock last traded at ₹1,017, a market capitalisation of ₹1,434 crore, on a P/E of 18.7. Over the past 52 weeks the stock has ranged between ₹735 and ₹1,250. Figures are as of 9 Oct 2026 and are not real time.
TTK Healthcare Ltd-$ share price and key metrics
- Current price
- ₹1,017
- Market cap
- ₹1,434 cr
- Stock P/E
- 18.7
- Book value
- ₹789
- ROE
- 6.30%
- ROCE
- 8.04%
- Dividend yield
- 0.98%
- 52w high / low
- 1250/735
Metrics as of 9 Oct 2026. Not real time.
Track TTK Healthcare Ltd-$
Cruxal reads every TTK Healthcare Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
TTK Healthcare Ltd-$ growth and returns
- 10 Years
- 5%
- 5 Years
- 12%
- 3 Years
- 6%
- TTM
- 8%
- 10 Years
- 12%
- 5 Years
- 11%
- 3 Years
- -52%
- TTM
- 14%
- 10 Years
- 0%
- 5 Years
- 8%
- 3 Years
- -4%
- 1 Year
- -12%
- 10 Years
- 19%
- 5 Years
- 22%
- 3 Years
- 7%
- Last Year
- 6%
TTK Healthcare Ltd-$ quarterly results
In the quarter ended Jun 2026, sales were ₹258 cr, up 14.2% from ₹226 cr a year earlier. Net profit was ₹21 cr, up 61.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 198 | 205 | 190 | 226 | 204 | 209 | 218 | 258 |
| Expenses | 190 | 197 | 178 | 224 | 198 | 202 | 207 | 243 |
| Operating profit | 8 | 8 | 12 | 3 | 5 | 7 | 11 | 15 |
| OPM % | 4.2% | 3.8% | 6% | 1.2% | 2.6% | 3.4% | 5% | 6% |
| Other income | 18 | 18 | 13 | 18 | 19 | 10 | 21 | 17 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 23 | 23 | 22 | 18 | 21 | 14 | 30 | 29 |
| Tax % | 26% | 26% | 26% | 26% | 4% | 25% | 26% | 26% |
| Net profit | 17 | 17 | 16 | 13 | 20 | 11 | 22 | 21 |
| EPS (₹) | 12.17 | 11.84 | 11.43 | 9.20 | 14.43 | 7.45 | 15.40 | 15.06 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
TTK Healthcare Ltd-$ annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 528 | 578 | 628 | 646 | 476 | 599 | 725 | 753 | 801 | 857 | 888 |
| Operating profit | 38 | 43 | 50 | 28 | 19 | 22 | 31 | 37 | 35 | 26 | 38 |
| OPM % | 7% | 7% | 8% | 4.4% | 4.1% | 3.6% | 4.3% | 5.0% | 4.3% | 3.0% | 4.3% |
| Net profit | 19 | 18 | 24 | 12 | 46 | 42 | 640 | 63 | 82 | 66 | 74 |
| EPS (₹) | 24.13 | 12.86 | 17.25 | 8.72 | 32.87 | 29.43 | 452.72 | 44.47 | 57.79 | 46.48 | 52.34 |
TTM is the trailing twelve months to the most recent quarter.
TTK Healthcare Ltd-$ balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 8 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 150 | 219 | 237 | 235 | 281 | 316 | 939 | 987 | 1,051 | 1,101 |
| Borrowings | 23 | 47 | 29 | 30 | 19 | 22 | 27 | 23 | 24 | 24 |
| Other liabilities | 104 | 127 | 136 | 152 | 180 | 207 | 189 | 183 | 192 | 190 |
| Total liabilities | 285 | 407 | 416 | 431 | 494 | 559 | 1,170 | 1,206 | 1,281 | 1,329 |
| Fixed assets | 99 | 110 | 98 | 89 | 85 | 80 | 71 | 75 | 81 | 73 |
| CWIP | 0 | 1 | 2 | 9 | 0 | 0 | 3 | 1 | 0 | 1 |
| Investments | 9 | 9 | 13 | 9 | 13 | 15 | 13 | 13 | 11 | 9 |
| Other assets | 177 | 288 | 304 | 325 | 395 | 463 | 1,083 | 1,118 | 1,189 | 1,246 |
| Total assets | 285 | 407 | 416 | 431 | 494 | 559 | 1,170 | 1,206 | 1,281 | 1,329 |
As reported by the company. Total assets equal total liabilities by construction.
TTK Healthcare Ltd-$ cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 18 | 25 | 17 | 20 | 96 | 45 | -25 | -5 | -4 | -21 |
| Cash from investing | 5 | -22 | 10 | -13 | -77 | -30 | 32 | 28 | 20 | 52 |
| Cash from financing | -23 | -7 | -31 | -10 | -17 | -10 | -12 | -22 | -18 | -18 |
| Net cash flow | 0 | -4 | -4 | -4 | 2 | 5 | -6 | 2 | -2 | 13 |
| Free cash flow | 12 | 21 | 13 | 8 | 95 | 42 | -36 | -15 | 6 | -25 |
| CFO / operating profit | 67% | 84% | 62% | 108% | 391% | 248% | -28% | 54% | 68% | -31% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
TTK Healthcare Ltd-$ operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 18% | 15% | 15% | 8% | 6% | 8% | 10% | 9% | 9% | 8% |
| Debtor days | 24 | 35 | 47 | 43 | 46 | 33 | 46 | 42 | 41 | 47 |
| Inventory days | 65 | 80 | 77 | 101 | 123 | 102 | 89 | 105 | 107 | 98 |
| Days payable | 100 | 130 | 101 | 121 | 170 | 134 | 116 | 110 | 106 | 83 |
| Cash conversion cycle | -11 | -16 | 22 | 23 | -2 | 1 | 19 | 36 | 43 | 63 |
| Working capital days | -24 | -30 | -6 | -3 | -32 | -28 | 4 | 49 | 48 | 161 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
TTK Healthcare Ltd-$ shareholding pattern
Promoters held 74.57% at Jun 2026, broadly unchanged since Jun 2025. FIIs 1.86% and DIIs 2.19%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.57% | 74.57% | 74.57% | 74.57% | 74.57% | 74.57% | 74.57% | 74.57% |
| FIIs | 1.90% | 1.90% | 1.90% | 1.89% | 1.90% | 1.89% | 1.90% | 1.86% |
| DIIs | 1.14% | 1.14% | 1.14% | 1.18% | 1.18% | 1.08% | 1.11% | 2.19% |
| Public | 22.39% | 22.39% | 22.40% | 22.37% | 22.37% | 22.46% | 22.43% | 21.39% |
| No. of shareholders | 15,762 | 15,780 | 15,899 | 16,112 | 16,134 | 22,481 | 23,686 | 22,809 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
TTK Healthcare Ltd-$ corporate filings
- Closure of Trading WindowInsider Trading / SASTlow impact
- TTK Healthcare Ltd: Routine Regulatory Filing under SEBI LODRCompany Updatelow impact
Cruxal's analysis: TTK Healthcare Ltd has filed a routine announcement under Regulation 30 of the SEBI…
Read the full analysis - TTK Healthcare Limited appoints M/s. R V K & Co. as Tax Auditor for a three-year termCompany Updatelow impact
Cruxal's analysis: TTK Healthcare Limited has announced the appointment of M/s. R V K & Co., Chartered…
Read the full analysis - TTK Healthcare Ltd: M/s Aiyar & Co. resigns as Tax AuditorsCompany Updatelow impact
Cruxal's analysis: TTK Healthcare Ltd has informed the exchange that M/s Aiyar & Co. have expressed their…
Read the full analysis - TTK Healthcare Ltd: Disclosure of Newspaper Publication regarding Corporate FilingsCompany Updatelow impact
Cruxal's analysis: TTK Healthcare Ltd has published a notice in newspapers as part of its regulatory…
Read the full analysis - TTK Healthcare reports strong Q1 FY27 performance and announces strategic divestment of EVA and Good Home brands for 256 croreBoard Meetinghigh impact
Cruxal's analysis: TTK Healthcare Limited reported a robust Q1 FY27 performance with revenue from operations…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.